Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous valve therapies.

Howard C Herrmann1

  • 1Hospital of the University of Pennsylvania, 3400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104, USA. howard.herrmann@uphs.upenn.edu

Current Treatment Options in Cardiovascular Medicine
|November 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Adverse Events on Costs and Length of Stay Following Transcatheter Tricuspid Valve Replacement.

Structural heart : the journal of the Heart Team·2026
Same author

Outcomes of Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves in Patients With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis of Observational Studies.

Structural heart : the journal of the Heart Team·2026
Same author

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Circulation. Cardiovascular interventions·2026
Same author

Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.

JAMA·2026
Same author

Cost-Effectiveness of Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement for Degenerated Bioprosthetic Mitral Valve.

Structural heart : the journal of the Heart Team·2026
Same author

Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve Replacement.

Journal of the American Heart Association·2026
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Innovations in treating valvular heart disease are emerging, including new bioprosthetic valves and repair techniques. These advancements offer less invasive options beyond balloon valvuloplasty, expanding treatment possibilities for more patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Valvular heart disease treatment has historically been limited, with balloon valvuloplasty as the primary nonsurgical option for stenosis.
  • Previous nonsurgical interventions lacked definitive solutions for aortic stenosis and were not designed for regurgitant valve lesions.

Purpose of the Study:

  • To highlight recent innovations in valvular heart disease treatment.
  • To discuss the potential of percutaneous valve repair and replacement techniques.
  • To explore the expansion of nonsurgical treatment options for a wider patient population.

Main Methods:

  • Introduction of self-expanding and balloon-expandable stents with bioprosthetic heart valves.
  • Development of novel valvular implants and techniques for repair and treatment.

Related Experiment Videos

  • Investigation of various percutaneous valve repair and replacement strategies.

    • Main Results:

    • Emergence of new interventional cardiology tools for valvular heart disease.
    • Potential for more definitive treatment of aortic stenosis compared to balloon valvuloplasty.
    • Capability to address regurgitant valve lesions through less invasive means.

    Conclusions:

    • The field of valvular heart disease treatment is at the cusp of significant growth due to technological advancements.
    • Percutaneous valve repair and replacement offer promising alternatives to traditional surgery for a broader range of patients.
    • Continued improvements in technology, techniques, and clinical experience are crucial for achieving surgical-level outcomes.